Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide-1 Receptor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07244445
What this trial is testing

Pistachio Intake and Nutrition-Related Outcomes in Individuals on GLP-1 Therapy

Who this might be right for
Dietary ChangeObesity & OverweightFood Acceptance
Ian J. Neeland, MD 108
Not applicableStudy completedNCT03241303
What this trial is testing

Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small Intestines

Who this might be right for
Glucose Metabolism Disorders
University Hospital, Gentofte, Copenhagen 15
Post-approval studies (Phase 4)Study completedNCT01911468
What this trial is testing

Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on Metformin

Who this might be right for
PCOSObesity
University Medical Centre Ljubljana 36
Not applicableLooking for participantsNCT06487832
What this trial is testing

Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness

Who this might be right for
Normal WeightOverweight and ObesityInsulin Sensitivity+1 more
University Hospital Tuebingen 60
Post-approval studies (Phase 4)Study completedNCT01899430
What this trial is testing

Polycystic Ovary Syndrome and Liraglutide

Who this might be right for
PCOSObesity
University Medical Centre Ljubljana 32
Not applicableStudy completedNCT06660134
What this trial is testing

Strict Weight Management Based on GLP-1 RA for Ablation Outcomes in Overweight or Obese Patients with T2DM and AF

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Atrial Fibrillation (AF)
Shanghai Chest Hospital 174
Not applicableNot Yet RecruitingNCT07276763
What this trial is testing

Impact of Discontinuing GLP-1 Receptor Agonists for Two Weeks Prior to Upper Endoscopy on the Risk of Gastric Retention

Who this might be right for
Gastric Retention
Fudan University 16,509
Post-approval studies (Phase 4)Study completedNCT02465515
What this trial is testing

Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
GlaxoSmithKline 9,463
Testing effectiveness (Phase 2)UnknownNCT05659368
What this trial is testing

Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1

Who this might be right for
Wolfram Syndrome
Ospedale San Raffaele 10
Not applicableLooking for participantsNCT07484061
What this trial is testing

Efficacy and Safety of a Drinkable Nutraceutical for Hair Loss in Patients Using GLP-1/GIP Receptor Agonists

Who this might be right for
Telogen Effluvium
Olistic Research Labs S.L. 40
Post-approval studies (Phase 4)Not Yet RecruitingNCT07715929
What this trial is testing

Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients

Who this might be right for
Atrial FibrillationObesity & OverweightCatheter Ablation
Yunlong Wang 710
Early research (Phase 1)Active Not RecruitingNCT05202353
What this trial is testing

A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver

Who this might be right for
Obesity
Boehringer Ingelheim 29
Not applicableUnknownNCT05990374
What this trial is testing

Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 Years

Who this might be right for
Diabetes
Nanjing First Hospital, Nanjing Medical University 100
Post-approval studies (Phase 4)Looking for participantsNCT07419854
What this trial is testing

Restoring Facial Volume After GLP-1 Weight Loss With Radiesse

Who this might be right for
Volume Loss (Soft Tissue Ptosis or Atrophy )
Kalpna Kay Durairaj, MD, FACS 48
Post-approval studies (Phase 4)UnknownNCT04122716
What this trial is testing

Combined Effects of GLP-1 Analogue and Exercise on Maintenance of Weight Loss and Health After Very-low Calorie Diet

Who this might be right for
Obesity
Signe Torekov 215
Post-approval studies (Phase 4)Study completedNCT06981936
What this trial is testing

This Randomized Trial Aims to Investigate the Efficacy of Balanced Nutritional Tablets-Comprehensive Multivitamin and Mineral Supplements- in Preventing Micronutrient Deficiencies Among Patients Utilizing GLP-1 RAs for Weight Loss in Comparison to a Placebo Control

Who this might be right for
Micronutrient Deficiencies
General Committee of Teaching Hospitals and Institutes, Egypt 150
Early research (Phase 1)Ended earlyNCT05668936
What this trial is testing

A Thorough QTC Study to Assess the Effect of Cotadutide on Cardiac Repolarization in Healthy Participants

Who this might be right for
Non-alcoholic Steatohepatitis
AstraZeneca 31
Not applicableLooking for participantsNCT07789223
What this trial is testing

Weight and Metabolic Management Study

Who this might be right for
OverweightObesityWeight Maintenance
Elenzia 200
Not applicableLooking for participantsNCT07006142
What this trial is testing

Effect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists

Who this might be right for
Upper EndoscopyGLP1-R-related Disease
Mayo Clinic 150
Early research (Phase 1)Study completedNCT06634927
What this trial is testing

Pharmacokinetic Similarity, Safety, and Immunogenicity of Semaglutide Injection and Ozempic ® Injection in Healthy Subjects.

Who this might be right for
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 68
Next Page